Evaluation of inflammatory biomarkers, carotid intima-media thickness and cardiovascular risk in HIV-1 treatment-naive patients.

INTRODUCTION Mortality among HIV patients is 3-15 times higher than that among the general population. Currently, most deaths are due to non-infectious diseases. Chronic inflammation and adverse events due to antiretroviral therapy play crucial roles in increasing cardiovascular risk (CVR). METHODS This cross-sectional study aimed to evaluate carotid intima-media thickness (CIMT) and inflammatory biomarkers (D-dimer, ADAMTS13, GDF-15, sICAM-1, MPO, myoglobin, NGAL, SAA, sVCAM-1, and p-selectin) among naïve patients. RESULTS Sixty-seven participants were included: median age, 32 years; males, 82.1%; non-white, 61.1%; higher education level, 62.7%; and exposed to HIV through sexual relationship (men who have sex with men), 68.7%. The median viral load and LTCD4+ value were 42,033 copies/mL and 426 cells/mm³. The prevalence of arterial hypertension was 16.4%; those of diabetes mellitus and dyslipidemia were 3% and 70.1%, respectively. The CIMT was 494.08 (± 96.84mm). The mean vascular age was 33.2 ± 18.9 years, one year longer than the chronological age, without statistical significance. CONCLUSIONS The majority of participants had a low CVR (94%). After reclassification, considering the CIMT percentiles, 13 (19.4%) patients had medium/ high CVR, while 54 (80.6%) patients had low CVR. The difference between the proportions of CVR when considering the CIMT and its corresponding percentile was statistically relevant. Body mass index was the only predictor of higher CVR (p = 0.03). No biomarker was found to predict CVR. People living with HIV have a high prevalence of dyslipidemia before ARV therapy.

[1]  R. Walensky,et al.  The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review , 2017, BMC Public Health.

[2]  H. R. Lacerda,et al.  Intima-Media Thickness in the Carotid and Femoral Arteries for Detection of Arteriosclerosis in Human Immunodeficiency Virus-Positive Individuals , 2017, Arquivos brasileiros de cardiologia.

[3]  M. McConnell,et al.  Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study , 2016, Journal of the American Heart Association.

[4]  B. Agan,et al.  D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events , 2016, PloS one.

[5]  D. Grobbee,et al.  Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review , 2016, PloS one.

[6]  M. Bukrinsky,et al.  HIV infection induces structural and functional changes in high density lipoproteins. , 2015, Atherosclerosis.

[7]  I. Benseñor,et al.  Low Impact of Traditional Risk Factors on Carotid Intima-Media Thickness: The ELSA-Brasil Cohort , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Bruce Bartholow Duncan,et al.  Prevalence, Awareness, Treatment and Influence of Socioeconomic Variables on Control of High Blood Pressure: Results of the ELSA-Brasil Study , 2015, PloS one.

[9]  L. Hurley,et al.  Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Valentini,et al.  Evaluation of late presentation for HIV treatment in a reference center in Belo Horizonte, Southeastern Brazil, from 2008 to 2010 , 2015, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[11]  R. Kronmal,et al.  Predictors of Carotid Thickness and Plaque Progression During a Decade: The Multi-Ethnic Study of Atherosclerosis , 2014, Stroke.

[12]  S. Grinspoon.  Cardiovascular disease in HIV: traditional and nontraditional risk factors. , 2014, Topics in antiviral medicine.

[13]  N. Williams.  The CAGE questionnaire. , 2014, Occupational medicine.

[14]  L. Ramos,et al.  Association of Inflammatory Cytokines and Endothelial Adhesion Molecules with Immunological, Virological, and Cardiometabolic Disease in HIV-Infected Individuals , 2014 .

[15]  J. Currier,et al.  Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? , 2014, JACC. Cardiovascular imaging.

[16]  V. Veloso,et al.  The HIV-Brazil Cohort Study: Design, Methods and Participant Characteristics , 2014, PloS one.

[17]  Andrew N. Phillips,et al.  Factors Associated with D-Dimer Levels in HIV-Infected Individuals , 2014, PloS one.

[18]  Stéphane Laurent,et al.  Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. , 2013, European heart journal.

[19]  J. Overbaugh,et al.  A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapy , 2013, BMC Infectious Diseases.

[20]  K. Kraemer,et al.  HIV infection and the risk of acute myocardial infarction. , 2013, JAMA internal medicine.

[21]  R. Paredes,et al.  Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population , 2013, AIDS.

[22]  R. Bosch,et al.  Study design issues in evaluating immune biomarkers , 2013, Current opinion in HIV and AIDS.

[23]  J. Stein.  Cardiovascular risk and dyslipidemia management in HIV-infected patients. , 2012, Topics in antiviral medicine.

[24]  J. Aberg.  Aging, inflammation, and HIV infection. , 2012, Topics in antiviral medicine.

[25]  S. Deeks,et al.  HIV infection, inflammation, immunosenescence, and aging. , 2011, Annual review of medicine.

[26]  W. Powderly.  Growing old with HIV — dealing with co-morbidities , 2010, Journal of the International AIDS Society.

[27]  R. Kronmal,et al.  Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study , 2009, AIDS.

[28]  T. Villines,et al.  HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies , 2009, Heart.

[29]  J. Polak.  Carotid Intima-Media Thickness: An Early Marker of Cardiovascular Disease , 2009, Ultrasound quarterly.

[30]  A. Phillips,et al.  HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity , 2009, BMJ : British Medical Journal.

[31]  Lewis H Kuller,et al.  Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.

[32]  M. Bukrinsky,et al.  HIV infection and high density lipoprotein metabolism. , 2008, Atherosclerosis.

[33]  Ross J. Harris,et al.  Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies , 2008, The Lancet.

[34]  L. Montaner,et al.  Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy , 2008, AIDS.

[35]  J. Neaton,et al.  CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection , 2008, AIDS.

[36]  Christopher B. Kendall,et al.  Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[37]  Hang Lee,et al.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. , 2007, The Journal of clinical endocrinology and metabolism.

[38]  D. Greco,et al.  [Corporal fat distribution and lipidic and glicemic profiles of HIV-infected patients]. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[39]  J Darbyshire,et al.  CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.

[40]  S. Sidney,et al.  The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. , 2006, American journal of epidemiology.

[41]  Pamela S Douglas,et al.  Vascular age: Integrating carotid intima‐media thickness measurements with global coronary risk assessment , 2004, Clinical cardiology.

[42]  M. Lederman,et al.  Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[44]  Gerardo Heiss,et al.  Carotid Artery Intimal‐Medial Thickness Distribution in General Populations As Evaluated by B‐Mode Ultrasound , 1993, Stroke.

[45]  D. B. Miranda-Filho,et al.  Association of inflammatory cytokines and endothelial adhesion molecules with immunological, virological, and cardiometabolic disease in HIV-infected individuals. , 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.